OTCMLQWC
Market cap422kUSD
Dec 26, Last price
0.01USD
1D
9.38%
1Q
-53.80%
Jan 2017
438.46%
Name
LifeQuest World Corp
Chart & Performance
P/E
—
P/S
1.99
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
75.51%
Rev. gr., 5y
129.82%
Revenues
212k
+41.31%
Net income
-171k
L-55.00%
CFO
-131k
L-49.48%
Earnings
Jan 17, 2025
Profile
LifeQuest World Corporation, through its subsidiaries, provides effluent treatment and sewage treatment solutions. The company develops onsite sewage wastewater treatment system, which treats grey and black water that can be reused for irrigation, flushing, and cleaning. It also focuses on providing solutions for treatment of effluents in textile, tannery, fisheries, dairy, and processed water industries. The company offers Biopipe, a biological wastewater treatment system that could be used in detached houses, commercial and multi-family buildings, hotels, hospitals, industrial complexes, campgrounds, and parks; and Abrimix, a water treatment technology for treating wastewater, processed water, or raw water. In addition, it provides Glanris, a non-toxic filtration media for water filtration for municipalities, businesses, homeowners, and consumers; and Goslyn, a grease recovery device to remove fats, oils, and grease from wastewater effluent. The company was incorporated in 1997 and is based in Ridgefield Park, New Jersey.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | 2016‑05 | |
| Income | |||||||||
Revenues | 212 41.31% | 150 -57.11% | 349 -36.39% | ||||||
Cost of revenue | 199 | 267 | 516 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 13 | (117) | (167) | ||||||
NOPBT Margin | 6.19% | ||||||||
Operating Taxes | 35 | 68 | (94) | ||||||
Tax Rate | 267.50% | ||||||||
NOPAT | (22) | (185) | (73) | ||||||
Net income | (171) -55.00% | (380) 74.71% | (217) -54.69% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 29 | 13 | 50 | ||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 2 | 8 | 2 | ||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (234) | (301) | (516) | ||||||
| Cash flow | |||||||||
Cash from operating activities | (131) | (259) | (238) | ||||||
CAPEX | (944) | (398) | |||||||
Cash from investing activities | (944) | 39 | (398) | ||||||
Cash from financing activities | 23 | 13 | 14 | ||||||
FCF | 31 | (45) | (485) | ||||||
| Balance | |||||||||
Cash | 237 | 310 | 517 | ||||||
Long term investments | |||||||||
Excess cash | 226 | 302 | 500 | ||||||
Stockholders' equity | (1,419) | (1,284) | (838) | ||||||
Invested Capital | 1,879 | 1,861 | 1,843 | ||||||
ROIC | |||||||||
ROCE | 2.85% | ||||||||
| EV | |||||||||
Common stock shares outstanding | 121,484 | 116,234 | 114,959 | ||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 81 | (54) | (125) | ||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||